A two-time cancer survivor and a perennial Republican swing voter, Senator Arlen Specter (R-PA), urged the creation of the Cures Acceleration Network, a new agency to provide grants to help biotech companies develop new treatments, reports Reuters and The Boston Globe:
I believe that we can live not only longer lives, but healthier lives, by harnessing [...]
Filed under: Congress, Finding Cures, In the News, Uncategorized | Tagged: Cures Acceleration Network, Specter | Leave a Comment »
Josh Green, general partner at MDV-Mohr Davidow Ventures and three entrepreneurs visited Capitol Hill on Wednesday to testify before the House Small Business Committee about the need to reauthorize the SBIR program.
The Wall Street Journal’s Venture Capital Dispatch blog reported,
“Companies receiving venture funding may have other innovation in the pipeline worth [...]
Filed under: Congress, In the News, SBIR, Uncategorized | Tagged: Congress, House Small Business Committee, SBIR, venture capital | 1 Comment »
The economic news this week wasn’t all doom and gloom – Google announced Google Ventures, a new venture capital fund that will finance biotechnology start ups, among other things.
According to Google Blog:
At its core, Google Ventures is charged with finding and helping to develop exceptional start-ups. We’ll be focusing on early stage investments across [...]
Filed under: BIO, In the News, venture capital | Tagged: biotechnology, Google, Innovation, start-up, VC, venture capital | Leave a Comment »
Canopy Group announces the launch of BizCafé, a unique website matching life science and high tech entrepreneurs with business opportunities, at www.IndianaBizCafe.com. The BizCafé automatically matches entrepreneurs, investors, and industry experts with opportunities and each other. The BizCafé is a one-stop shop for SBIR/STTR grants and federal procurement; it captures 99% of all available feeds, [...]
Filed under: In the News, venture capital | Leave a Comment »
Buried somewhere in the middle of Friday’s first Presidential debate, Democrat Barack Obama states that:
“The third thing we have to do is we’ve got to make sure that we’re competing in education. We’ve got to invest in science and technology. China had a space launch and a space walk. We’ve got to make [...]
Filed under: In the News, SBIR | Tagged: biotech, Presidential Debate, SBIR | 1 Comment »
On August 22, The Boston Globe ran an editorial discussing the SBIR bill created by Senator Kennedy, stating:
Kennedy and Rudman created the program because the work of small companies was often considered too risky and too preliminary to attract venture capital money. Supporters of the program fear that the House bill will dampen the kind [...]
Filed under: Congress, In the News, SBIR, venture capital | Tagged: Congress, SBIR, Senator Kennedy | 1 Comment »
Stories are appearing nationally that highlight the importance of SBIR funding in partnership with venture capital dollars on local economies. These investment capital/government funding partnerships can foster growth in the biotech industry. This is the best way to ensure that our scientists are able to develop cutting-edge treatments and therapies and bring them to the [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: BIO, biotech, Kansas City, Kansas Enterprise Technology Corp, Rep. Graves, SBIR, Senate, Senator Bond | Leave a Comment »
In St. Louis, another small biotech firm is contemplating what steps to take if the SBIR bill is not renewed soon. Currently, Kereos Inc., a 15-employee company studying promising new methods of detecting and treating cancer is excluded from the SBIR program. This piece in Sunday’s St. Louis Post Dispatch illustrates the struggles that many [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: BIO, biotech, House Small Business Committee, Mark Heesen, SBIR, Senate, VC | Leave a Comment »
The Senate Small Business Committee has passed an SBIR reauthorization bill. We hope the House and Senate will work together to pass a final reauthorization bill before this program is set to expire on September 30, 2008.
From the Puget Sound Business Journal:
Under a compromise negotiated in the U.S. Senate, small companies that are majority-owned [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: BIO, Biotechnology industry, Jim Greenwood, NIH, SBA, SBIR, Senate Small Business Committee, VC, vc-owned firms | 1 Comment »
